Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

NCT04960579

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope Goodyear, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

NCT06868667

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Aomori, Japan
  • GSK Investigational Site Fukuoka, Japan
  • GSK Investigational Site Himeji, Japan
  • GSK Investigational Site Kamakura, Japan
View all 16 locations
View Trial Details
Active, Not Recruiting

Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products

NCT06738485

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Children's Hospital Beijing, Beijing Municipality, China
  • Children's Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 20 locations
View Trial Details
Active, Not Recruiting

Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

NCT04246047

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Yuma, Arizona, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Kansas City, Kansas, United States
  • GSK Investigational Site Fairfield, Ohio, United States
View all 69 locations
View Trial Details
Active, Not Recruiting

China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

NCT06868654

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Beijing, China
  • GSK Investigational Site Changchun, China
  • GSK Investigational Site Guangzhou, China
  • GSK Investigational Site Hangzhou, China
View Trial Details
Active, Not Recruiting

A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT03164057

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • Children's Hospital of Central California Madera, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Rady Children's Hospital and Health Center San Diego, California, United States
View Trial Details
Active, Not Recruiting

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

NCT05428969

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • University of Texas, MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions